Methicillin-resistant staphylococcus aureus (MRSA) infections are
caused due to Staphylococcus aureus bacterium which infects different parts of
the body. These infections are difficult to treat due to high degree of
resistance of these pathogens to the most commonly used antibiotics such as
methicillin, amoxicillin, penicillin and oxacillin. The bacterium infects
different parts of the body namely, skin, surgical wounds, blood streams,
lungs, IV or other sites where the tubes such as catheters enter the body or
the urinary tract and cause infection which can be life threatening.
MRSA infection is known to spread by casual contact or through
contaminated objects called community associated MRSA (CA MRSA). It may also be
acquired in hospitals or health care settings - healthcare associated MRSA (HA
MRSA) which is the most common form of MRSA infection. Community associated
methicillin resistant S. aureus (CA-MRSA) infections are different from
healthcare associated methicillin resistant S. aureus (HA-MRSA) considering
their epidemiology and the characteristics of the strains which causes the
infection. Overuse of antibiotics and use of potent drugs for less serious
infections may also cause development of MRSA. The symptoms of infection depend
on the site of infection and it can be diagnosed by laboratory testing.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/mrsa-drugs-market.html
One of the major
drivers contributing to the market growth for MRSA drugs is increase in the
prevalence of MRSA infections. In addition, growth in the government and
non-government awareness programs has also become a key factor in improving the
market growth. However, overcoming the tendency of pathogen for developing
resistance to multi-drugs and increase in competition between the generic
market players could impose a challenge to the market growth.
MRSA can be usually
treated by antibiotics such as bactrim and vancomycin though the pathogen has
started developing resistance for these drugs too owing to its constant
adapting power to newly developed antibiotics. Other options for the treatment
of MRSA infection are generics such as clindamycin and minocycline, and prime
brand-names such as Tygacil, Cubicin, Zyvox, and Synercid. Some of these
antibiotics are only available intravenously. The most effective way of
controlling the spread of MRSA is practicing basic hygiene such as use of
disposable gloves, washing hands before making direct contact with patients as
well as proper wound care.
Geographically, North
America leads this market and is followed by Europe. However, increase in the
development of healthcare infrastructure in emerging economies forecasts growth
in demand for MRSA drugs in Asia-Pacific and other parts of the world. Some of
the major players in this market include Takeda Pharmaceutical Company Limited,
Merck & Co., Inc, AstraZeneca PLC, GlaxoSmithKline PLC, Pfizer, Inc.,
Cubist Pharmaceuticals, Inc., ViroPharma, Inc., Forest Laboratories, Inc., and
Theravance, Inc.
Download PDF : Methicillin-Resistant Staphylococcus Aureus Drugs Market
This
research report analyzes this market depending on its market segments, major
geographies, and current market trends. Geographies analyzed under this
research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides
comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming
years
This report is a
complete study of current trends in the market, industry growth drivers, and
restraints. It provides market projections for the coming years. It includes
analysis of recent developments in technology, Porter’s five force model
analysis and detailed profiles of top industry players. The report also
includes a review of micro and macro factors essential for the existing market
players and new entrants along with detailed value chain analysis.
Reasons for Buying this
Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological growth
map over time to understand the industry growth rate
- It provides a seven-year forecast
assessed on the basis of how the market is predicted to grow
·
It helps in making informed business
decisions by having complete insights of market and by making in-depth analysis
of market segments.
More Reports On Pharmaceutical
Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us:-
Transparency Market
Research (TMR) is a market intelligence company providing global business
research reports and consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights for thousands
of decision-makers.
TMR’s
experienced team of analysts, researchers, and consultants use proprietary data
sources along with various tools and techniques to gather and analyze
information. Our business offerings represent the latest and the most reliable
information which is indispensable for businesses to sustain their competitive
edge.
Our
data repository is continuously updated and revised by a team of research
experts so that it always reflects the latest trends and information. With
broad research and analysis capability, Transparency Market Research employs
rigorous primary and secondary research techniques in developing distinctive
data sets and research material for business reports.
Contact Us
Sheela AK
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Browse
Market Researche Report:-
No comments:
Post a Comment